In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, ...
Eli Lilly is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using ...
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses ...
As a federal court in Texas hears a case pitting the FDA versus compounders who want to continue to manufacture cheaper ...
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...
Eli Lilly is partnering with Imagine Entertainment and MACRO to drive industry-wide change and guide in authentically ...
Eli Lilly and Company (NYSE: LLY ... for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity.1 Zepbound may help adults with moderate-to-severe obstructive sleep apnea ...
Obesity drugs, durable revenue bringing Big Money investors to Eli Lilly and Company (LLY).
Novo Nordisk (NVO) stock in focus as company launches its direct-to-consumer platform NovoCare Pharmacy for Wegovy delivery.
Impact of US Tariffs and Obesity Drug Performance on the Pharmaceutical ... In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback